The management of hormone-relapsed prostate cancer

被引：13

作者：

Clarke, NW

机构：

[1] Christie Hosp NHS Trust, Dept Surg, Manchester M20 4BX, Lancs, England

[2] Salford Royal Hosp NHS Trust, Manchester, Lancs, England

来源：

BJU INTERNATIONAL | 2003年 / 92卷 / 08期

关键词：

SPINAL-CORD COMPRESSION; QUALITY-OF-LIFE; METASTATIC BONE-DISEASE; URETERAL OBSTRUCTION; DOUBLE-BLIND; CYTOTOXIC CHEMOTHERAPY; CONTROLLED-TRIAL; ORAL CLODRONATE; CARCINOMA; PALLIATION;

D O I：

10.1046/j.1464-410X.2003.04494.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

It is important that although HRPC is incurable it is not untreatable. The clinical management embraces many interventional and supportive therapies, and for optimal treatment a multidisciplinary approach is ultimately the best for the patient. In all of this it is vital that the care is patient-centred, and that the pastoral and psychological needs of the individual are appropriately addressed in the course of managing the physical needs of men with this disease.

引用

页码：860 / 868

页数：9

共 87 条

[71] Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton [J].

Soerdjbalie-Maikoe, V ;

Pelger, RCM ;

Nijeholt, GABL ;

Arndt, JW ;

Zwinderman, AH ;

Papapoulos, SE ;

Hamdy, NAT .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (04) :494-498

[72] DERANGEMENTS OF CALCIUM METABOLISM IN PATIENTS WITH NEOPLASTIC BONE INVOLVEMENT [J].

SPENCER, H ;

LEWIN, I .

JOURNAL OF CHRONIC DISEASES, 1963, 16 (07) :713-+

[73] The effect of a single fraction compared to multiple fractions on painful bone metastases:: a global analysis of the Dutch Bone Metastasis Study [J].

Steenland, E ;

Leer, J ;

van Houwelingen, H ;

Post, WJ ;

van den Hout, WB ;

Kievit, J ;

de Haes, H ;

Martijn, H ;

Oei, B ;

Vonk, E ;

van der Steen-Banasik, E ;

Wiggenraad, RGJ ;

Hoogenhout, J ;

Wárlám-Rodenhuis, C ;

van Tienhoven, G ;

Wanders, R ;

Pomp, J ;

van Reijn, M ;

van Mierlo, T ;

Rutten, E .

RADIOTHERAPY AND ONCOLOGY, 1999, 52 (02) :101-109

[74] Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points [J].

Tannock, IF ;

Osoba, D ;

Stockler, MR ;

Ernst, DS ;

Neville, AJ ;

Moore, MJ ;

Armitage, GR ;

Wilson, JJ ;

Venner, PM ;

Coppin, CML ;

Murphy, KC .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (06) :1756-1764

[75] DEATHS AND COMPLICATIONS FOLLOWING PROSTATECTOMY IN 1400 MEN IN THE NORTHERN REGION OF ENGLAND [J].

THORPE, AC ;

CLEARY, R ;

COLES, J ;

VERNON, S ;

REYNOLDS, J ;

NEAL, DE .

BRITISH JOURNAL OF UROLOGY, 1994, 74 (05) :559-565

[76]

TIERNAN E, 2000, UROONCOLOGY, V1, P7

[77]

TOFE AJ, 1975, J NUCL MED, V16, P986

[78]

TONG D, 1982, CANCER-AM CANCER SOC, V50, P893, DOI 10.1002/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO

[79]

2-Y

[80]

Townsend MF, 1997, CANCER, V79, P545, DOI 10.1002/(SICI)1097-0142(19970201)79:3<545::AID-CNCR17>3.0.CO

← 1 2 3 4 5 6 7 8 9 →